28,71 €
0,19 %vorgestern
L&S, 23. Februar, 22:54 Uhr
ISIN
GB00BMVP7Y09
Symbol
RPRX
Berichte
Sektor
Industrie

Royalty Pharma plc - Ordinary Shares - Class A Aktie News

Positiv
The Motley Fool
9 Tage alt
SLB expects strong growth in 2024. Alibaba stock is dirt cheap, and the company plans major buybacks over the next few years.
Neutral
Seeking Alpha
9 Tage alt
Royalty Pharma PLC (RPRX) Q4 2023 Earnings Call Transcript
Neutral
GlobeNewsWire
10 Tage alt
NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter and full year of 2023 and introduced full year 2024 guidance for Portfolio Receipts. “Royalty Pharma delivered outstanding results in 2023,” said Pablo Legorreta, Royalty Pharma's founder and Chief Executive Officer. “We reported another year of strong growth in ...
Positiv
InvestorPlace
17 Tage alt
The technology applied in the field of medicine undoubtedly surprises more and more investors every day. As technology advances in the world, biotech companies are in charge of applying it to improve the quality of life of all human beings.
Neutral
GlobeNewsWire
25 Tage alt
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2023 financial results on Thursday, February 15, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day.
Positiv
Seeking Alpha
etwa ein Monat alt
Royalty Pharma is a unique pharmaceutical company that diversifies investments in market-leading or late-stage development therapies. RPRX has a dominant position in the pharmaceutical royalty market and shares in the profits of successful pharmaceutical development projects. The outlook is getting better driven by strong industry tailwinds like new technologies in developing drugs and treatmen...
Neutral
GlobeNewsWire
etwa ein Monat alt
NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2024 of $0.21 per Class A share, reflecting a 5% increase in the company's quarterly dividend over the previous quarter's dividend.
Neutral
GlobeNewsWire
3 Monate alt
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 6th Annual HealthCONx Conference on November 28, 2023 at 3:00 p.m. ET.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen